A. Alzheimer, Über eine eigenartige Erkrankung der Hirnrinde, Allg Zeitschrift fur Psychiatr und Psych Medizin, vol.64, pp.146-148, 1907.

R. A. Stelzmann, H. N. Schnitzlein, and F. R. Murtagh, An English translation of Alzheimer's 1907 paper, Clin Anat, vol.8, issue.6, p.8713166, 1995.

E. Kraepelin, Psychiatrie. Ein Lehrbuch Für Studierende Und Ärzte. II. Bd., Klinische Psychiatrie. 8. Auflage. Leipzig, 1910.

F. Boller, . History, and . Dementia, Handb Clin Neurol, vol.89, pp.1201-1209, 2008.

B. T. Hyman, C. H. Phelps, and T. G. Beach, National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

, Alzheimers Dement, vol.8, issue.1, pp.1-13, 2012.

O. Fischer, Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz, Monatsschr Psychiat Neurol, vol.22, pp.361-372, 1907.

L. A. Amaducci, W. A. Rocca, and B. S. Schoenberg, Origin of the distinction between

, Alzheimer's disease and senile dementia: how history can clarify nosology, Neurology, vol.36, issue.11, pp.1497-1499, 1986.

M. Holstein, Alzheimer's disease and senile dementia, 1885-1920: An interpretive history of disease negotiation, J Aging Stud, vol.11, issue.1, pp.90008-90014, 1997.

M. Goedert and B. Ghetti, Alois Alzheimer: His Life and Times, Brain Pathol, vol.17, issue.1, pp.57-62, 2007.

A. Alzheimer, Über eigenartige Krankheitsfälle des späteren Alters, Zbl Ges Neurol Psych, vol.4, pp.356-385, 1911.

R. Katzman, R. Terry, and K. Bick, Alzheimer's Disease: Senile Dementia and Related 23

. Disorders, , 1978.

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, p.6610841, 1984.

B. Reisberg, S. H. Ferris, and M. J. De-leon, Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type, Drug Dev Res, vol.15, issue.2-3, pp.101-114, 1988.

R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos et al., Mild cognitive impairment: clinical characterization and outcome, Arch Neurol, vol.56, issue.3, p.10190820, 1999.

R. C. Petersen, R. Doody, and A. Kurz, Current concepts in mild cognitive impairment, Arch Neurol, vol.58, issue.12, p.11735772, 2001.

R. C. Petersen, Mild cognitive impairment as a diagnostic entity, J Intern Med, vol.256, issue.3, pp.183-194, 2004.

G. A. Jicha, J. E. Parisi, and D. W. Dickson, Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia, Arch Neurol, vol.63, issue.5, p.674, 2006.

T. G. Beach, S. E. Monsell, L. E. Phillips, and W. Kukull, Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, J Neuropathol Exp Neurol, vol.71, issue.4, pp.266-273, 2005.

,

B. Dubois and M. L. Albert, Amnestic MCI or prodromal Alzheimer's disease?, Lancet Neurol, vol.3, issue.4, pp.246-248, 2004.

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta, vol.24

. Neuropathol, , vol.82, p.1759558, 1991.

A. Delacourte, J. P. David, and N. Sergeant, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, Neurology, vol.52, issue.6, p.10214737, 1999.

D. R. Thal, U. Rüb, M. Orantes, and H. Braak, Phases of A beta-deposition in the human brain and its relevance for the development of AD, Neurology, vol.58, issue.12, pp.1791-1800, 2002.

M. Sarazin, V. Chauviré, and E. Gerardin, The amnestic syndrome of hippocampal type in Alzheimer's disease: An MRI study, J Alzheimer's Dis, vol.22, issue.1, pp.285-294, 2010.

M. Fouquet, B. Desgranges, L. Joie, and R. , Role of hippocampal CA1 atrophy in memory encoding deficits in amnestic Mild Cognitive Impairment, Neuroimage, vol.59, issue.4, pp.3309-3315, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00642176

H. Hampel, K. Bürger, S. J. Teipel, A. Bokde, H. Zetterberg et al., Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimer's Dement, vol.4, pp.38-48, 2008.

S. Lista, F. G. Garaci, and M. Ewers, CSF A?1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

&. Alzheimer and . Dement, , vol.10, pp.381-392, 2014.

S. Lista, H. Zetterberg, B. Dubois, K. Blennow, and H. Hampel, Cerebrospinal fluid analysis in Alzheimer's disease: Technical issues and future developments, J Neurol, vol.261, issue.6, pp.1234-1243, 2014.

B. Dubois, H. H. Feldman, and C. Jacova, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, vol.6, issue.8, p.17616482, 2007.

C. Jack, M. S. Albert, and D. S. Knopman, Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement J Alzheimer's Assoc, p.25

, , pp.257-262

B. Dubois, H. H. Feldman, and C. Jacova, Revising the definition of Alzheimer's disease: a new lexicon, Lancet Neurol, vol.9, issue.11, pp.70223-70227, 2010.

C. R. Jack, D. S. Knopman, and W. J. Jagust, Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet Neurol, vol.9, issue.1, pp.70299-70305, 2010.

J. A. Hardy and G. A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, issue.5054, pp.184-185, 1992.

R. A. Sperling, P. S. Aisen, and L. A. Beckett, Toward defining the preclinical stages of Alzheimer's disease: recommendations from the

, Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

, Alzheimers Dement, vol.7, issue.3, pp.280-292, 2011.

E. M. Reiman, K. Chen, and G. E. Alexander, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia, Proc Natl Acad Sci U S A, vol.101, issue.1, pp.284-289, 2004.

E. Reiman, R. J. Caselli, and L. S. Yun, Preclinical evidence of alzheimer's disease in persons homozygous for the, NEnglJ Med, vol.334, issue.12, p.8592548, 1996.

S. L. Risacher, A. J. Saykin, J. D. West, L. Shen, H. A. Firpi et al., Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort, Curr Alzheimer Res, vol.6, issue.4, pp.347-361, 2009.

B. Dubois, H. H. Feldman, and C. Jacova, Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria, Lancet Neurol, vol.13, issue.6, pp.614-629, 2014.

B. Dubois, H. Hampel, and H. H. Feldman, Alzheimer's Disease: Definition, Natural History, and Diagnostic Criteria, vol.12, 2016.

C. R. Jack, D. A. Bennett, and K. Blennow, Toward a biological definition of Alzheimer's disease, vol.14, pp.535-562, 2018.

H. Braak, D. R. Thal, E. Ghebremedhin, D. Tredici, and K. , Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years, J Neuropathol Exp Neurol, vol.70, issue.11, pp.960-969, 2011.

C. R. Jack, D. S. Knopman, and W. J. Jagust, Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, issue.2, pp.207-216, 2013.

R. Sperling, E. Mormino, and K. Johnson, The evolution of preclinical Alzheimer's disease: implications for prevention trials, Neuron, vol.84, issue.3, pp.608-622, 2014.

F. Kametani and M. Hasegawa, Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease, Front Neurosci, vol.12, p.25, 2018.

G. Chételat, Reply: The amyloid cascade is not the only pathway to AD, Nat Rev Neurol, vol.9, issue.6, p.356, 2013.

J. F. Crary, J. Q. Trojanowski, and J. A. Schneider, Primary age-related tauopathy (PART): a common pathology associated with human aging, Acta Neuropathol, vol.128, issue.6, pp.755-766, 2014.

G. M. Mckhann, D. S. Knopman, and H. Chertkow, The diagnosis of dementia due to Alzheimer's disease: recommendations from the

, Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

, Alzheimer's Dement J Alzheimer's Assoc, vol.7, pp.263-269, 2011.

, Alzheimer's Disease International, World Alzheimer Report, 2009.

M. J. Leon, . De, E. Pirraglia, and R. S. Osorio, The nonlinear relationship between cerebrospinal fluid A ? 42 and tau in preclinical Alzheimer ' s disease, vol.2018, p.27

C. Falcon, A. Tucholka, and G. C. Monté-rubio, Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets, NeuroImage Clin, vol.19, pp.190-201, 2018.

C. L. Sutphen, M. S. Jasielec, and A. R. Shah, Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age, JAMA Neurol, vol.72, issue.9, pp.1029-1042, 2015.

G. D. Rabinovici, M. C. Carrillo, and M. Forman, Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development, vol.3, pp.83-91, 2017.

J. A. Schneider, Z. Arvanitakis, W. Bang, and D. A. Bennett, Mixed brain pathologies account for most dementia cases in community-dwelling older persons, Neurology, vol.69, issue.24, p.17568013, 2007.

A. L. Pierce, S. S. Bullain, and C. H. Kawas, Late-Onset Alzheimer Disease, Neurol Clin, vol.35, issue.2, pp.283-293, 2017.

J. L. Robinson, E. B. Lee, and S. X. Xie, Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated, Brain, vol.141, issue.7, pp.2181-2193, 2018.

O. Yokota, T. Miki, and C. Ikeda, Neuropathological comorbidity associated with argyrophilic grain disease, Neuropathology, vol.38, issue.1, pp.82-97, 2018.

E. J. Chung, G. M. Babulal, S. E. Monsell, N. J. Cairns, C. M. Roe et al., Clinical Features of Alzheimer Disease With and Without Lewy Bodies, JAMA Neurol, vol.72, issue.7, p.789, 2015.

K. A. Josephs, D. W. Dickson, and N. Tosakulwong, Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study, Lancet Neurol, vol.16, issue.11, pp.917-924, 2017.

Y. Fujino, D. Wang, N. Thomas, M. Espinoza, P. Davies et al., Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry, J Neuropathol Exp Neurol, vol.64, issue.3, pp.209-214, 2005.

J. B. Toledo, N. J. Cairns, and X. Da, Clinical and multimodal biomarker correlates of ADNI neuropathological findings, Acta Neuropathol Commun, vol.1, issue.1, p.65, 2013.

E. Liu, M. E. Schmidt, and R. Margolin, Amyloid-? 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials, Neurology, vol.85, issue.8, pp.692-700, 2015.

H. Hampel, N. Toschi, and C. Babiloni, Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology, J Alzheimer
URL : https://hal.archives-ouvertes.fr/hal-01910402

. Preprint, , pp.1-59

P. T. Nelson, J. Q. Trojanowski, and E. L. Abner, New old pathologies": Ad, part, and cerebral age-related TDP-43 with sclerosis (CARTS), J Neuropathol Exp Neurol, vol.75, issue.6, pp.482-498, 2016.

R. A. Miech, J. Breitner, P. P. Zandi, A. S. Khachaturian, J. C. Anthony et al., Incidence of AD may decline in the early 90s for men, later for women: The Cache County study, Neurology, vol.58, issue.2, pp.209-218, 2002.

. Accessed, , 2018.

L. Fratiglioni, L. J. Launer, and K. Andersen, Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, vol.54, issue.11, pp.10-15, 2000.

F. Matthews, C. Brayne, I. Mrccf, and . As, The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study

R. J. Harvey and E. , PLoS Med, vol.2, issue.8, p.193, 2005.

S. Gao, H. C. Hendrie, K. S. Hall, and S. Hui, The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis, Arch Gen Psychiatry, vol.55, issue.9, pp.809-815, 1998.

C. B. Hall, J. Verghese, and M. Sliwinski, Dementia incidence may increase more slowly after age 90: Results from the Bronx Aging Study, Neurology, vol.65, issue.6, pp.882-886, 2005.

K. A. Jellinger and J. Attems, Prevalence of dementia disorders in the oldest-old: an autopsy study, Acta Neuropathol, vol.119, issue.4, pp.421-433, 2010.

, The Global Impact of Dementia An analysis of prevalence, incidence, cost and trends, World Alzheimer Report, 2015.

M. Ganguli, H. H. Dodge, C. Shen, R. S. Pandav, and S. T. Dekosky, Alzheimer Disease and Mortality, Arch Neurol, vol.62, issue.5, p.779, 2005.

C. Wattmo, E. Londos, and L. Minthon, Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up, Dement Geriatr Cogn Disord, vol.38, issue.5-6, pp.286-299, 2014.

B. S. Shastry and F. J. Giblin, Genes and susceptible loci of Alzheimer's disease, Brain Res Bull, vol.48, issue.2, pp.121-127, 1999.

X. Zhu, L. Tan, and H. Wang, Rate of early onset Alzheimer's disease: a systematic review and meta-analysis, Ann Transl Med, vol.3, issue.3, p.38, 2015.

T. S. Wingo, J. J. Lah, A. I. Levey, and D. J. Cutler, Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease, Arch Neurol, vol.69, issue.1, p.59, 2012.

M. Gatz, C. A. Reynolds, and L. Fratiglioni, Role of Genes and Environments for Explaining Alzheimer Disease, Arch Gen Psychiatry, vol.63, issue.2, p.168, 2006.

A. I. Jarmolowicz, H. Chen, and P. K. Panegyres, The Patterns of Inheritance in Early-Onset Dementia, Am J Alzheimer's Dis Other Dementiasr, vol.30, issue.3, pp.299-306, 2015.

C. M. Van-duijn, P. De-knijff, and M. Cruts, Apolipoprotein E4 allele in a populationbased study of early-onset Alzheimer's disease, Nat Genet, vol.7, issue.1, pp.74-78, 1994.

D. Campion, C. Dumanchin, and D. Hannequin, Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum, Am J Hum Genet, vol.65, issue.3, pp.664-670, 1999.

N. Brouwers, K. Sleegers, and C. Van-broeckhoven, Molecular genetics of Alzheimer's disease: An update, Ann Med, vol.40, issue.8, pp.562-583, 2008.

K. E. Wisniewski, A. J. Dalton, C. Mclachlan, G. Y. Wen, and H. M. Wisniewski, Alzheimer's disease in Down's syndrome: clinicopathologic studies, Neurology, vol.35, issue.7, pp.957-961, 1985.

K. E. Wisniewski, H. M. Wisniewski, and G. Y. Wen, Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome, Ann Neurol, vol.17, issue.3, pp.278-282, 1985.

M. Hersi, B. Irvine, P. Gupta, J. Gomes, N. Birkett et al., Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence, Neurotoxicology, vol.61, pp.143-187, 2017.

E. H. Corder, A. M. Saunders, and W. J. Strittmatter, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-923, 1993.

L. A. Farrer, L. A. Cupples, and J. L. Haines, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A metaanalysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA, vol.278, issue.16, pp.1349-1356, 2018.

P. T. Nelson, E. Head, and F. A. Schmitt, Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies, Acta Neuropathol, vol.121, issue.5, pp.571-587, 2011.

E. L. Abner, P. T. Nelson, and R. J. Kryscio, Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology, Alzheimers Dement, vol.12, issue.8, pp.882-889, 2016.

M. Dos-santos-matioli, C. K. Suemoto, and R. D. Rodriguez, Diabetes is Not Associated with Alzheimer's Disease Neuropathology. J Alzheimer's Dis, vol.60, pp.1035-1043, 2017.

T. Ribot, Les Maladies de La Mémoire. Paris: Baillière; 1881

F. Eustache, B. Giffard, and G. Rauchs, La maladie d'Alzheimer et la mémoire humaine, Rev ?, pp.929-939, 2006.

W. B. Scoville and B. Milner, Loss of recent memory after bilateral hippocampal lesions, J Neurol Neurosurg Psychiatry, vol.20, issue.1, pp.11-21, 1957.

R. S. Rosenbaum, S. Köhler, and D. L. Schacter, The case of K.C.: contributions of a memory-impaired person to memory theory, Neuropsychologia, vol.43, issue.7, pp.989-1021, 2005.

E. Grober, H. Buschke, and S. R. Korey, Genuine Memory Deficits in Dementia, Dev Neuropsychol, vol.3, issue.1, pp.13-36, 1987.

H. Tounsi, B. Deweer, and A. M. Ergis, Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease, Alzheimer Dis Assoc Disord, vol.13, issue.1, pp.38-46, 1999.

B. Desgranges, J. Baron, and G. B. , The neural basis of intrusions in free recall 32 and cued recall: a PET study in Alzheimer's disease, Neuroimage, vol.17, issue.3, pp.1658-1664, 2002.

M. Teichmann, S. Epelbaum, and D. Samri, Free and Cued Selective Reminding Testaccuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD), vol.13, pp.913-923, 2017.

M. Sarazin, C. Berr, D. Rotrou, and J. , Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study, Neurology, vol.69, issue.19, pp.1859-1867, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00169640

L. Rami, C. Solé-padullés, and J. Fortea, Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD, Int J Geriatr Psychiatry, vol.27, issue.2, pp.127-134, 2012.

C. A. Derby, L. C. Burns, and C. Wang, Screening for predementia AD: Time-dependent operating characteristics of episodic memory tests, Neurology, vol.80, issue.14, pp.1307-1314, 2013.

M. Wagner, S. Wolf, and F. M. Reischies, Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease, Neurology, vol.78, issue.6, pp.379-386, 2012.

J. J. Gomar, M. T. Bobes-bascaran, C. Conejero-goldberg, P. Davies, and T. E. Goldberg, Initiative for the ADN. Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging Initiative, Arch Gen Psychiatry, vol.68, issue.9, p.961, 2011.

A. Estévez-gonzález, J. Kulisevsky, A. Boltes, P. Otermín, and C. García-sánchez,

, Alzheimer's disease: comparison with mild cognitive impairment and normal aging, Int J Geriatr Psychiatry, vol.18, issue.11, pp.1021-1028, 2003.

E. Barbeau, M. Didic, and E. Tramoni, Evaluation of visual recognition memory in MCI 33 patients, Neurology, vol.62, issue.8, pp.1317-1322, 2004.

D. Sala, S. Parra, M. A. Fabi, K. Luzzi, S. Abrahams et al., Short-term memory binding is impaired in AD but not in non-AD dementias, Neuropsychologia, vol.50, issue.5, pp.833-840, 2012.

M. A. Parra, S. Abrahams, R. H. Logie, L. G. Méndez, F. Lopera et al., Visual short-term memory binding deficits in familial Alzheimer's disease, Brain, vol.133, issue.9, pp.2702-2713, 2010.

M. S. Mega, J. L. Cummings, T. Fiorello, and J. Gornbein, The spectrum of behavioral changes in Alzheimer's disease, Neurology, vol.46, issue.1, pp.130-135, 1996.

L. S. Honig and R. Mayeux, Natural history of Alzheimer's disease. Aging (Milano), vol.13, pp.171-182, 2001.

D. Pandis and N. Scarmeas, Seizures in Alzheimer disease: clinical and epidemiological data, Epilepsy Curr, vol.12, issue.5, pp.184-187, 2012.

S. Nag, L. Yu, and A. W. Capuano, Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease, Ann Neurol, vol.77, issue.6, pp.942-952, 2015.

P. T. Nelson, E. L. Abner, and F. A. Schmitt, Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from alzheimer disease, J Neuropathol Exp Neurol, vol.68, issue.7, pp.774-784, 2009.

Y. Saito, N. N. Ruberu, and M. Sawabe, Staging of Argyrophilic Grains: An AgeAssociated Tauopathy, J Neuropathol Exp Neurol, vol.63, issue.9, pp.911-918, 2004.

Y. S. Shim, C. M. Roe, V. D. Buckles, and J. C. Morris, Clinicopathologic study of Alzheimer's disease: Alzheimer mimics, J Alzheimers Dis, vol.35, issue.4, pp.799-811, 2013.

L. Guennec, K. Quenez, O. Nicolas, and G. , 31 duplication causes prominent taurelated dementia with increased MAPT expression, Mol Psychiatry, vol.22, issue.8, pp.1119-1125, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01832142

S. G. Lindquist, I. E. Holm, and M. Schwartz, Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation, Eur J Neurol, vol.15, issue.4, pp.377-385, 2008.

L. Ber, I. Camuzat, A. Hannequin, and D. , Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study, Brain, vol.131, issue.3, pp.732-746, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00280762

M. E. Murray, A. Cannon, and N. R. Graff-radford, Differential clinicopathologic and genetic features of late-onset amnestic dementias, Acta Neuropathol, vol.128, issue.3, pp.411-421, 2014.

A. Adeli, R. Savica, and V. J. Lowe, The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome, Neurocase, vol.20, issue.1, pp.110-120, 2014.

K. S. Santacruz, S. J. Rottunda, J. P. Meints, E. L. Bearer, E. H. Bigio et al., A case of globular glial tauopathy presenting clinically as alzheimer disease, Alzheimer Dis Assoc Disord, vol.29, issue.1, pp.82-84, 2015.

H. Fujishiro, S. Nakamura, M. Kitazawa, K. Sato, and E. Iseki, Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using123I-MIBG cardiac scintigraphy, J Neurol Sci, vol.315, issue.1-2, pp.115-119, 2012.

S. Palmqvist, J. Hertze, and L. Minthon, Comparison of brief cognitive tests and csf biomarkers in predicting alzheimer's disease in mild cognitive impairment: Six-year follow-up study, PLoS One, vol.7, issue.6, pp.1-7, 2012.

C. A. Fredericks, M. Koestler, W. Seeley, B. Miller, A. Boxer et al., Primary chronic traumatic encephalopathy in an older patient wiht late-onset AD phenotype, Neurol Clin Pract, vol.5, issue.6, pp.475-479, 2015.

L. T. Grinberg, R. Anghinah, and C. F. Nascimento, Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player, J Alzheimer's Dis, vol.54, issue.1, pp.169-174, 2016.

R. Guerreiro, J. Brás, A. Wojtas, R. Rademakers, J. Hardy et al., Nonsense mutation in PRNP associated with clinical Alzheimer's disease, Neurobiol Aging, vol.35, issue.11, 2014.

L. Cousyn, D. Grabli, and D. Seilhean, First European case of Creutzfeldt-Jakob disease with a PRNP G114V mutation, 2018.

A. L. Pitel, H. Beaunieux, and T. Witkowski, Episodic and Working Memory Deficits in Alcoholic Korsakoff Patients: The Continuity Theory Revisited, Alcohol Clin Exp Res, vol.32, issue.7, pp.1229-1241, 2008.

S. Kim, Y. H. Um, S. C. Lim, and J. Jeong, Limbic Encephalitis Manifesting as Selective Amnesia and Seizure-like Activity: A Case Report, Clin Psychopharmacol Neurosci, vol.16, issue.1, pp.109-113, 2018.

D. A. Bennett, R. S. Wilson, P. A. Boyle, A. S. Buchman, and J. A. Schneider, Relation of neuropathology to cognition in persons without cognitive impairment, Ann Neurol, vol.72, issue.4, pp.599-609, 2012.

C. Helmstaedter and C. E. Elger, Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease?, Brain, vol.132, issue.10, 2009.

S. Arlt and . Non, Alzheimer's disease-related memory impairment and dementia, Dialogues Clin Neurosci, vol.15, issue.4, pp.465-473, 2013.

S. Sorbi, J. Hort, and T. Erkinjuntti, EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia, Eur J Neurol, vol.19, issue.9, pp.1159-1179, 2012.

C. J. Galton, K. Patterson, J. H. Xuereb, and J. R. Hodges, Atypical and typical presentations of 36

, Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases, Brain, vol.123, issue.3, pp.484-498, 2000.

J. S. Snowden, C. L. Stopford, and C. L. Julien, Cognitive phenotypes in Alzheimer's disease and genetic risk, Cortex, vol.43, issue.7, pp.835-845, 2007.

M. E. Murray, N. R. Graff-radford, O. A. Ross, R. C. Petersen, R. Duara et al., Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study, Lancet Neurol, vol.10, issue.9, pp.70156-70165, 2011.

S. J. Crutch, J. M. Schott, and G. D. Rabinovici, Consensus classification of posterior cortical atrophy, vol.13, pp.870-884, 2017.

S. J. Ross, N. Graham, and L. Stuart-green, Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease, J Neurol Neurosurg Psychiatry, vol.61, issue.4, pp.388-395, 1996.

J. A. Renner, J. M. Burns, C. E. Hou, D. W. Mckeel, M. Storandt et al., Progressive posterior cortical dysfunction: A clinicopathologic series, Neurology, vol.63, issue.7, pp.1175-1180, 2004.

D. F. Tang-wai, N. R. Graff-radford, and B. F. Boeve, Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy, Neurology, vol.63, issue.7, pp.1168-1174, 2004.

S. Alladi, J. Xuereb, and T. Bak, Focal cortical presentations of Alzheimer's disease, Brain, vol.130, issue.10, pp.2636-2645, 2007.

S. J. Crutch, M. Lehmann, J. M. Schott, G. D. Rabinovici, M. N. Rossor et al., Posterior cortical atrophy, Lancet Neurol, vol.11, issue.2, pp.70289-70296, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01289466

M. L. Gorno-tempini, . Hillis-a-e, and S. Weintraub, Classification of primary progressive aphasia and its variants, Neurology, vol.76, issue.11, pp.1006-1014, 2011.

J. M. Harris, C. Gall, and J. C. Thompson, Classification and pathology of primary progressive aphasia, Neurology, vol.81, issue.21, pp.1832-1839, 2013.

M. M. Mesulam, S. Weintraub, E. J. Rogalski, C. Wieneke, C. Geula et al., Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia, Brain, vol.137, issue.4, pp.1176-1192, 2014.

E. G. Spinelli, M. L. Mandelli, and Z. A. Miller, Typical and atypical pathology in primary progressive aphasia variants, Ann Neurol, vol.81, issue.3, pp.430-443, 2017.

J. K. Johnson, E. Head, R. Kim, A. Starr, and C. W. Cotman, Clinical and pathological evidence for a frontal variant of Alzheimer disease, Arch Neurol, vol.56, issue.10, pp.1233-1239, 1999.

M. Woodward, C. Jacova, and S. E. Black, Differentiating the frontal variant of Alzheimer's disease, Int J Geriatr Psychiatry, vol.25, issue.7, pp.732-738, 2009.

R. Ossenkoppele, Y. Pijnenburg, and D. C. Perry, The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features, Brain, vol.138, issue.9, pp.2732-2749, 2015.

K. Rascovsky, J. R. Hodges, and D. Knopman, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, vol.134, issue.9, pp.2456-2477, 2011.

H. J. Rosen, M. L. Gorno-tempini, and W. P. Goldman, Patterns of brain atrophy in frontotemporal dementia and semantic dementia, Neurology, vol.58, issue.2, pp.198-208, 2002.

J. Shi, C. L. Shaw, D. Plessis, and D. , Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation, Acta Neuropathol, vol.110, issue.5, pp.501-512, 2005.

G. C. Léger and S. J. Banks, Neuropsychiatric Symptom Profile Differs Based on Pathology in Patients with Clinically Diagnosed Behavioral Variant Frontotemporal Dementia

, Dement Geriatr Cogn Disord, vol.37, issue.1-2, pp.104-112, 2014.

D. C. Perry, J. A. Brown, and K. L. Possin, Clinicopathological correlations in behavioural variant frontotemporal dementia, Brain, vol.140, issue.12, pp.3329-3345, 2017.

K. R. Daffner, Current Approaches to the Clinical Diagnosis of Alzheimer's Disease, Early Diagnosis of Alzheimer's Disease, vol.2012, pp.29-64

M. J. Armstrong, I. Litvan, and A. E. Lang, Criteria for the diagnosis of corticobasal degeneration, Neurology, vol.80, issue.5, pp.496-503, 2013.

S. E. Lee, G. D. Rabinovici, and M. C. Mayo, Clinicopathological correlations in corticobasal degeneration, Ann Neurol, vol.70, issue.2, pp.327-340, 2011.

D. Stefano, F. Kas, A. Habert, and M. O. , The phenotypical core of Alzheimer's diseaserelated and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study, vol.12, pp.786-795, 2016.

K. Kasanuki, K. A. Josephs, and T. J. Ferman, Diffuse Lewy body disease manifesting as corticobasal syndrome: A rare form of Lewy body disease, Neurology, vol.91, issue.3, pp.268-279, 2018.

M. F. Mendez, Early-Onset Alzheimer Disease, Neurol Clin, vol.35, issue.2, pp.263-281, 2017.

K. J. Chang, C. H. Hong, and K. S. Lee, Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis, J Alzheimer's Dis, vol.56, issue.4, pp.1341-1348, 2017.

A. Joshi, J. M. Ringman, A. S. Lee, K. O. Juarez, and M. F. Mendez, Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease, J Neurol, vol.259, issue.10, pp.2182-2188, 2012.

C. Rupp, K. Beyreuther, K. Maurer, and S. Kins, A presenilin 1 mutation in the first case of Alzheimer's disease: Revisited. Alzheimer's Dement, vol.10, pp.869-872, 2014.

U. Müller, P. Winter, and M. B. Graeber, A presenilin 1 mutation in the first case of Alzheimer's disease, Lancet Neurol, vol.12, issue.2, pp.70307-70308, 2013.

M. Goedert, Oskar Fischer and the study of dementia, Brain, vol.132, issue.4, pp.1102-1111, 2009.